Bupropion is a commonly prescribed antidepressant, but overdose can lead to seizures, cardiac conduction abnormalities, and even cardiogenic shock. In this episode of PEM Currents, pediatric emergency medicine physicians Dr. Xavier Idriss and Dr. Becca Spegele discuss the clinical presentation, pharmacology, and management of bupropion toxicity in children and adolescents. Learn why seizures can be delayed for up to 24 hours, how to manage neurologic and cardiovascular complications, and what determines observation, admission, and disposition.

 

Learning Objectives

After listening to this episode, learners should be able to:

  1. Recognize the clinical manifestations of bupropion toxicity, including early neurologic warning signs, delayed seizures, and cardiovascular complications.
  2. Describe the acute management of bupropion overdose, including benzodiazepine administration, gastrointestinal decontamination, cardiac monitoring, and supportive care.
  3. Determine appropriate observation periods and disposition based on bupropion formulation, clinical presentation, and severity of toxicity.

References

  1. Cincinnati Drug and Poison Information Center. Bupropion toxicity. Published 2024. Accessed October 2026.
  2. Rianprakaisang T, Blumenberg A, Hendrickson RG. Characteristics and frequency of bupropion overdose with a delayed seizure. J Med Toxicol. 2021;17(1):45-52. DOI not provided.
  3. Starr P, Klein-Schwartz W, Spiller H, Kern P, Ekleberry SE, Kunkel S. Incidence and onset of delayed seizures after overdoses of extended-release bupropion. Am J Emerg Med. 2009;27(8):911-915. doi:10.1016/j.ajem.2008.07.004
  4. Offerman S, Gosen J, Thomas SH, Padilla-Jones A, Ruha AM, Levine M. Bupropion associated seizures following acute overdose: who develops late seizures. Clin Toxicol (Phila). 2020;58(12):1306-1312. DOI not provided.
  5. Beuhler MC, Spiller HA, Sasser HC. The outcome of unintentional pediatric bupropion ingestions: a NPDS database review. J Med Toxicol. 2010;6(1):4-8. doi:10.1007/s13181-010-0034-2

Script

The following is the original edited episode script, with minor grammatical corrections.

Why Bupropion Is So Dangerous

Today we’re talking about bupropion, also called Wellbutrin, Zyban, or Aplenzin.

Bupropion is a unicyclic antidepressant, and structurally it’s actually a cousin of amphetamines. It’s commonly prescribed, both for depression and for smoking cessation, which also means it’s readily available in households where young children may accidentally ingest it or adolescents may take it intentionally.

Bupropion has such a narrow seizure margin that it was actually pulled from the market in 1986 after seizures were reported at daily doses of 400 to 600 milligrams. It returned three years later with lower recommended doses, but seizures can still occur, even at therapeutic doses and in patients without a seizure history. And in overdose, toxicity can be delayed, particularly with sustained- and extended-release formulations. That delay is important, and we’ll come back to it throughout this episode.

How Kids Present

So what does this kid look like when they arrive in your ED?

Think about three organ systems: the brain, the heart, and the gut. But understand that the brain is where the real trouble lives.

Let’s start with the CNS. Tremors and seizures are the effects you’re most worried about. With immediate-release formulations, seizures typically occur within the first few hours. But with sustained- and extended-release products, seizures can be delayed for up to 24 hours after ingestion. In fact, seizures have been reported in approximately one-third of bupropion overdose cases.

Classically, these are one or two brief generalized tonic-clonic seizures that resolve on their own, but recurrent seizures and status epilepticus can occur. Some patients have a prodrome before seizing, typically consisting of agitation, tremors, and hallucinations. If you see that triad, consider it a warning shot. You may also see paresthesias, lightheadedness, lethargy, and confusion.

Moving to the cardiovascular system, sinus tachycardia is common, and you may see some hypertension. QRS widening, QT prolongation, and other conduction abnormalities are less common but can occur with more severe toxicity.

Cardiogenic shock has also been reported. It’s uncommon, but it completely changes how you resuscitate, so keep it in the back of your mind if the patient becomes hypotensive.

And the gut? Nausea and vomiting. That’s about it.

Putting it all together, the typical patient is tachycardic, agitated, maybe tremulous, and the thing you’re really watching and waiting for is a seizure.

Pharmacology Pearls

Let’s talk through the pertinent pharmacology. Here’s the take-home pearl of this section: delayed and prolonged toxicity are common.

Bupropion’s time to peak is roughly two hours for immediate-release, three hours for sustained-release, and five hours for extended-release formulations. And its active metabolites peak even later, around six hours after ingestion.

The half-life of bupropion ranges from four to twenty-four hours at therapeutic doses, while its active metabolites can stick around even longer, with half-lives ranging from nine to forty-three hours. That prolonged exposure, particularly with sustained- and extended-release formulations, helps explain why our observation windows are so long.

Bupropion inhibits dopamine and norepinephrine reuptake, and the resulting CNS stimulation is thought to contribute to its seizure risk.

Two more quick notes. First, bupropion isn’t effectively removed by hemodialysis because of its large volume of distribution and high protein binding, so don’t count on dialysis to help in an overdose.

Second, when you see QRS widening, it’s primarily due to impaired cardiac gap-junction communication rather than sodium-channel blockade. That’s an important distinction because it means sodium bicarbonate may not work the way it does for other toxic ingestions.

Management and Observation

Alright, so what do you actually do when caring for a patient with bupropion toxicity?

First, before anything else: supportive care. Airway, breathing, circulation. Stabilize the patient first.

Then the fundamentals: cardiac monitor, IV or IO access, a glucose check, and an ECG. On that ECG, you’re hunting for tachycardia, QRS widening, and QT prolongation. And keep in mind there’s no routine blood or urine assay for bupropion, so this is primarily a clinical, history-driven diagnosis.

Now let’s walk through the specific problems.

For seizures and significant agitation, your answer is IV benzodiazepines. They can also help with the associated hypertension and tachycardia, although those findings don’t necessarily require treatment on their own.

For hypotension, consider a bedside echo. This is where that rare cardiogenic shock can come back to bite you. Assessing cardiac function can help guide your fluid resuscitation and choice of vasoactive medications, particularly if the patient isn’t responding as expected.

For QRS widening, sodium bicarbonate is reasonable to try, especially if you’re concerned about a possible co-ingestion. However, as we mentioned earlier, bupropion’s effects on cardiac conduction aren’t primarily due to sodium-channel blockade, so bicarbonate may not be effective.

In severe cases with refractory cardiovascular collapse, intravenous lipid emulsion and even VA-ECMO have been used as rescue therapies. These are uncommon situations where you’ll want toxicology and critical care involved early.

Now, decontamination. Consider activated charcoal for a potentially toxic ingestion, particularly if the patient presents early and can safely receive it. Although charcoal is most effective early, it may still be useful several hours after ingestion, especially with large ingestions or sustained- and extended-release formulations.

Whole bowel irrigation may also be worth considering for selected large modified-release ingestions. These are decisions to make with Poison Control and Medical Toxicology, especially given the risk of sudden seizures and aspiration.

Finally, observation. For potentially toxic immediate-release ingestions, a minimum of twelve hours of observation is a reasonable approach. Sustained- and extended-release ingestions generally require admission and monitoring for twenty-four hours because of the risk of delayed seizures. The exact duration should be individualized based on the dose, formulation, symptoms, and Poison Control recommendations.

Disposition

So who goes home, and who stays?

Home: An asymptomatic child after a confirmed immediate-release ingestion can potentially go home, but only after completing the recommended observation period without symptoms, typically at least twelve hours for a potentially toxic ingestion, and always in coordination with Poison Control.

Remember, every intentional ingestion needs a psychiatric evaluation before that patient is discharged, whether that be from the emergency department or inpatient setting.

Admit: Patients with potentially toxic sustained- or extended-release ingestions generally warrant admission and monitoring for twenty-four hours. The delayed seizures are just too unpredictable to gamble on. Even with immediate-release products, patients who develop symptoms may require admission.

ICU: Anyone with recurrent seizures, status epilepticus, hemodynamic instability, cardiogenic shock, or significant conduction abnormalities.

Three Take-Homes

Let’s close with three things to carry out of here.

Number one: bupropion is a seizure-causing drug first. Watch for agitation, tremors, and hallucinations as warning signs, and remember that benzodiazepines are your first-line treatment for seizures.

Number two: respect the delayed clock. Potentially toxic immediate-release ingestions generally warrant at least twelve hours of observation. Sustained- and extended-release ingestions may require a full twenty-four hours of observation and admission. Seizures can occur long after the patient initially looks well, even ten or more hours later.

And number three: don’t forget the heart. Cardiogenic shock is rare but real. If your patient becomes hypotensive, get a bedside echo to assess cardiac function and help guide your resuscitation.

 

Comment (0)

No comments yet. Be the first to say something!